Pharmaceutical

Novo Nordisk secures FDA approval for Ozempic in diabetes with CKD

The approval solidifies Novo Nordisk’s Ozempic as the most broadly indicated GLP-1RA in the US.

Jan 30, 2025 - 06:00
Novo Nordisk secures FDA approval for Ozempic in diabetes with CKD
The approval solidifies Novo Nordisk’s Ozempic as the most broadly indicated GLP-1RA in the US.
Read the original article

Tags:

Previous Article

Lantheus acquires radiopharma CDMO Evergreen for up to $1bn

Next Article

Sonnet BioTherapeutics secures EU patent for FHAB technology

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Mental illness, drug addiction go hand in glove, Biden’s drug czar tells lawmakers

STAT+: Mental illness, drug addiction go hand in glove,...

Jul 30, 2023

J&J’s Darzalex combination gains expanded label for multiple myeloma in Europe

J&J’s Darzalex combination gains expanded label for mul...

Oct 24, 2024

STAT+: Protesters slam health insurance lobby for Medicare Advantage coverage restrictions

STAT+: Protesters slam health insurance lobby for Medic...

Jun 28, 2023